Key Melanoma Trials at ASCO Yield Encouraging Survival Data

Hello. I am Dr Jeffrey Weber, deputy director of the Perlmutter Cancer Center at New York University Langone Health in New York City and co-director of its melanoma research program. Welcome to Medscape Oncology Insights.

Today I will briefly discuss some of the emerging data on melanoma treatment that was presented at the 2018 meeting of the American Society of Clinical Oncology (ASCO). We have heard about a number of interesting new trials and seen follow-ups of old trials.

read the original full article